影响肾癌患者预后的相关因素分析(2)
 |
| 第1页 |
参见附件。
[2] Cairns P. Renal cell carcinoma[J]. Cancer Biomark，2010，9(1-6)：461-473.
[3] Harano M，Eto M，Yokomizo A，et al. Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinoma[J]. Fukuoka Igaku Zasshi，2007，98(11)：389-396.
[4] Matrana MR，Ng C，Rao P，et al. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib： a case report[J]. Clin Genitourin Cancer，2011，9(2)：137-139.
[5] Caso J，Tidwell J，Tsivian M，et al. Stapled renal vein with in situ tumor thrombus： a useful intraoperative maneuver to facilitate radical nephrectomy and inferior vena cava thrombectomy[J]. Urology，2011，77(1)：217-222.
[6] Feng X，Bao J，Jing Z，et al. Tempofilter II for tumor emboli prevention during radical nephrectomy and inferior vena cava thrombus resection for renal cell carcinoma[J]. J Surg Oncol，2009，100(2)：159-162.
[7] Rosenblatt J，McDermott DF. Immunotherapy for renal cell carcinoma[J]. Hematol Oncol Clin North Am，2011，25(4)：793-812.
(收稿日期：2012-10-22)
您现在查看是摘要介绍页，详见PDF附件(2612kb)。